Back to Market Feed

PREGABALIN ER 330 MG TABLET

PREGABALIN
$3.2741per EA
High Outlier
DEA Schedule CV

Strength

330 mg/1

NDC

72205007930

Classification

Generic

Dosage Form

TABLET, FILM COATED, EXTENDED RELEASE

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

PREGABALIN

Approval Type

Generic (ANDA)

FDA Application

ANDA213226

On Market Since

4/13/2021

Price History

1W

0.0%

1M

-5.5%

3M

-10.7%

6M

-12.1%

1Y

+22.1%

3Y

N/A

5Y

N/A

All

+1.9%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

No related drugs found.